Literature DB >> 17987853

[Association of paracoccidioidomycosis with different pulmonary pathologies in a hospital in Corrientes Province, Argentina].

A M Pato1, G Giusiano, M Mangiaterra.   

Abstract

For 2 years, a systematic research of paracoccidioidomycosis (PCM) had been conducted in a hospital in the city of Corrientes. The inclusion criterium used was: tuberculosis patients (TBC), presumptive or confirmed diagnosis of pulmonary cancer (CA), chronic obstructive pulmonary disease (COPD) and/or X-ray images compatible with pulmonary mycosis (XRC). Eighty four patients were studied: 57 (TBC), 1 (CA), 5 (COPD), 3 (TBC+CA), 4 (TBC+COPD), 4 (COPD+CA) and 10 (XRC). Serology tests by agar gel immunodiffusion (IDGA) were performed on all patients, whereas microbiological studies were performed on those cases in which clinical samples could be obtained. Ten PCM were diagnosed by IDGA; 4 associated to TBC, 1 to TBC+CA, 3 to COPD and only 2 to XRC. PCM was mycologically proven in 9 of these cases. Systematic research of PCM would lead to an early diagnosis and therefore, to better chances for a successful treatment.

Entities:  

Mesh:

Year:  2007        PMID: 17987853

Source DB:  PubMed          Journal:  Rev Argent Microbiol        ISSN: 0325-7541            Impact factor:   1.852


  2 in total

1.  Western blotting is an efficient tool for differential diagnosis of paracoccidioidomycosis and pulmonary tuberculosis.

Authors:  Thâmara Aline Bertoni; Maysa Cláudia Zolin Perenha-Viana; Eliana Valéria Patussi; Rosilene Fressatti Cardoso; Terezinha Inez Estivalet Svidzinski
Journal:  Clin Vaccine Immunol       Date:  2012-09-12

2.  Synchronous oral paracoccidioidomycosis and pulmonary tuberculosis in an immunocompetent patient.

Authors:  Ana Carolina Amorim Pellicioli; Rodrigo Neves-Silva; Alan Roger Santos-Silva; Pablo Agustin Vargas; Márcio Ajudarte Lopes
Journal:  Mycopathologia       Date:  2015-02-05       Impact factor: 2.574

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.